Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

International Stem Cell (ISCO) Times Interest Earned (2016 - 2025)

International Stem Cell (ISCO) has disclosed Times Interest Earned for 16 consecutive years, with $2.2 as the latest value for Q2 2025.

  • On a quarterly basis, Times Interest Earned fell 48.38% to $2.2 in Q2 2025 year-over-year; TTM through Jun 2025 was -$0.57, a 85.63% increase, with the full-year FY2024 number at -$0.47, up 90.17% from a year prior.
  • Times Interest Earned was $2.2 for Q2 2025 at International Stem Cell, up from -$71.67 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $4.26 in Q2 2024 to a low of -$71.67 in Q1 2025.
  • A 5-year average of -$9.27 and a median of -$3.48 in 2023 define the central range for Times Interest Earned.
  • Biggest YoY gain for Times Interest Earned was 203.47% in 2024; the steepest drop was 9000.0% in 2024.
  • International Stem Cell's Times Interest Earned stood at -$8.28 in 2021, then surged by 122.32% to $1.85 in 2022, then tumbled by 774.64% to -$12.47 in 2023, then surged by 110.49% to $1.31 in 2024, then soared by 68.03% to $2.2 in 2025.
  • Per Business Quant, the three most recent readings for ISCO's Times Interest Earned are $2.2 (Q2 2025), -$71.67 (Q1 2025), and $1.31 (Q4 2024).